CD40LG and neoplasm: The T cell response in mice treated with anti-CD40L at implantation appeared to be above background, but was not significantly different from that detected in SIY-tolerant mice (Fig. 3aiv), suggesting that this represents a relatively ‘silent’ tumor implantation.